Lexaria Bioscience Corp. (LEXX)

1.19 +0.06 (+5.31%) USD  |  NASDAQ  |  Dec 10, 15:32
More

Lexaria Bioscience EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Oncolytics Biotech, Inc. --
Aurinia Pharmaceuticals, Inc. --
Edesa Biotech, Inc. --
Xenon Pharmaceuticals, Inc. --
ProMIS Neurosciences, Inc. --